Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified

scientific article published on November 15, 2010

Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/10428194.2010.529204
P953full work available at URLhttp://www.tandfonline.com/doi/pdf/10.3109/10428194.2010.529204
P698PubMed publication ID21077742

P2093author name stringWei Zhang
Liang Wang
Daobin Zhou
Yongji Wu
Dachun Zhao
Quancai Cui
P2860cites workThe biology of VEGF and its receptorsQ27860704
Tumour-educated macrophages promote tumour progression and metastasisQ29614307
The current status of lymphoma classificationQ33940248
Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progressionQ35835003
Macrophages and the hypoxic tumour microenvironmentQ36813993
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosisQ37398320
Tumor-associated macrophages as targets for tumor immunotherapy.Q37773280
High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.Q46845329
Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi.Q48608139
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomasQ61641369
Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomachQ73276399
[The 2008 WHO lymphoma classification]Q79788213
Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumabQ81189195
CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasisQ82782774
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectperipheral T-cell lymphomaQ7168693
P304page(s)46-52
P577publication date2010-11-15
P1433published inLeukemia & LymphomaQ6534493
P1476titleExpression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified
P478volume52

Reverse relations

cites work (P2860)
Q33408536Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).
Q38388719CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas
Q38097963Carcinoma-associated fibroblasts, its implication in head and neck squamous cell carcinoma: a mini review
Q99211990Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas
Q37662219GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T cell lymphoma
Q83133759High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma
Q40174970High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma
Q40922483High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type
Q84075664High numbers of tumor-associated macrophages correlate with poor prognosis in patients with mature T- and natural killer cell lymphomas
Q39070526Hypoxia-related gene expression profile in childhood acute lymphoblastic leukemia: prognostic implications
Q44328764Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis
Q35029454Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells
Q44861189Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma
Q92981904Mutual editing of alternative splicing between breast cancer cells and macrophages
Q28072045New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy
Q94570254Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16-/CD16 + monocyte ratio
Q53148664Prognostic significance of neuron-specific enolase in patients with diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.
Q39978774Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
Q36284948Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes
Q33632109TIE-2 expressing monocytes in human cancers.
Q38581916The role of alisertib in treatment of peripheral T-cell lymphomas
Q38391574VEGF overexpression is a valuable prognostic factor for non-Hodgkin's lymphoma evidence from a systemic meta-analysis